Accelerating Long-Read NGS for Gene Therapy with Genedata Selector
Long-read next-generation sequencing (NGS) offers significant potential for gene therapy quality control, but processing and analyzing large sequencing datasets can limit its use in time-sensitive workflows. Fujifilm Biotechnologies sought to accelerate nanopore sequencing analysis while enabling deeper characterization of adeno-associated virus (AAV) samples.
In this case study, we show how Genedata Selector® enabled automated nanopore basecalling and downstream QC analysis through configurable Playbooks, reducing processing time by approximately 90%, from 61 hours to 4 hours. The integrated workflow also supported contamination detection, confirmation of sample identity, and reproducible results, helping researchers generate QC-relevant insights faster and apply long-read NGS more effectively in quality control operations.